Combination Therapy for Atopic Dermatitis

NCT00119158 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Combination of pimecrolimus and fluticasone
DRUG: pimecrolimus

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]